Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Cross-linked Hyaluronic Acid hydrogels have proven to be excellent fillers for the volumetric augmentation of soft tissues.
The advanced crosslinking technologies have allowed high rheological levels to allow the use of in several anatomical areas with more resistance to degradation of the implant. In recent years, some have studied new types of cross-linkers to enhance the rheological features of the hydrogel.

Materials / method: For the determination of cell viability and cytotoxicity of NEAUVIA hydrogels MTT test, NRU test and Kenacid Blue test have been performed.
To evaluate the morphological evidences following pegyleted filler treatment in human skin histological and immunohistochemical studies have been performed.
To optimize clinical outcomes, we promote both needle and techniques.

Results: No alterations in cell morphology and viability were detected, which shows of complete biosafety. On the basis of our histological observations, the filler used in this study is safe, and shows no sign of stimulation of the immune system and/or any other adverse reactions.

Conclusion: A new PEG crosslinked HA filler is now available. The aim of our communication will be to explain in vivo and in vitro research on the new molecule in order to provide documentary evidence of its safety and efficacy in the aesthetic and clinic correction of soft tissues. We will also show the clinical technique of Neauvia gel implants.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): Consultant

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability